A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

NCT03024255 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

227

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperhidrosis

Interventions

DRUG: BBI-4000 gel, 5%
DRUG: BBI-4000 gel, 10%
DRUG: BBI-4000 gel, 15%
DRUG: Vehicle (Placebo)

Sponsor

Botanix Pharmaceuticals